HCM
BMY icon

Hillman Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Hillman Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.22M Sell
53,102
-864
-2% -$50.4K 2.24% 21
2025
Q4 		$2.91M Sell
53,966
-15,474
-22% -$744K 1.83% 21
2025
Q3 		$3.13M Sell
69,440
-2,375
-3% -$111K 1.82% 23
2025
Q2 		$3.32M Buy
71,815
+6,796
+10% +$334K 1.81% 29
2025
Q1 		$3.97M Sell
65,019
-49,652
-43% -$2.89M 1.95% 26
2024
Q4 		$6.49M Sell
114,671
-45,774
-29% -$2.56M 2.41% 21
2024
Q3 		$8.3M Sell
160,445
-84
-0.1% -$3.94K 2.85% 14
2024
Q2 		$6.67M Buy
+160,529
New +$7.18M 2.35% 22
2022
Q2 		– Sell
-135,731
Closed -$9.91M – 49
2022
Q1 		$9.91M Buy
135,731
+1,794
+1% +$120K 3.15% 4
2021
Q4 		$8.35M Sell
133,937
-4,351
-3% -$255K 2.87% 16
2021
Q3 		$8.18M Buy
138,288
+20,231
+17% +$1.33M 2.87% 18
2021
Q2 		$7.89M Buy
118,057
+950
+0.8% +$61.9K 3% 16
2021
Q1 		$7.39M Buy
117,107
+33,117
+39% +$2.06M 3.24% 17
2020
Q4 		$5.21M Buy
83,990
+316
+0.4% +$19.4K 2.81% 20
2020
Q3 		$5.04M Sell
83,674
-352
-0.4% -$21.2K 3.55% 6
2020
Q2 		$4.94M Sell
84,026
-904
-1% -$54.1K 3.6% 8
2020
Q1 		$4.73M Sell
84,930
-1,711
-2% -$105K 4.53% 4
2019
Q4 		$5.56M Buy
+86,641
New +$4.96M 3.94% 3

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hillman Capital Management's BMY Position: Q1 2026 in Review

Hillman Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 1.6% in Q1 2026, selling an estimated $50.4K and leaving 53,102 shares worth $3.22M. The position accounts for 2.24% of the portfolio, ranked #21.

Hillman Capital Management first reported a position in BMY in Q4 2019 and has held it in 18 quarters since. The position peaked at $9.91M in Q1 2022. 2,528 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Hillman Capital Management held 53,102 shares of Bristol-Myers Squibb worth $3.22M as of Q1 2026.
  • Hillman Capital Management sold 864 Bristol-Myers Squibb shares in Q1 2026, an estimated $50.4K.
  • Bristol-Myers Squibb made up 2.24% of Hillman Capital Management's portfolio in Q1 2026, its #21 holding.
  • Hillman Capital Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 18 quarters since.
  • Hillman Capital Management's Bristol-Myers Squibb position peaked at $9.91M in Q1 2022.
  • 2,528 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Hillman Capital Management's 13F filing for Q1 2026, filed 15 May 2026.